Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study

Author:

Rost Natalia S.1ORCID,Meschia James F.2ORCID,Gottesman Rebecca3ORCID,Wruck Lisa4,Helmer Karl5,Greenberg Steven M.1ORCID,Barrett Kevin,Biffi Alessandro,Boden-Albala Bernadette,Fornage Myriam,Etherton Mark,Golland Polina,Graff-Radford Jonathan,Hinman Jason,Jack Cliff,Kalpathy-Cramer Jayashree,Knopman David,Kittner Steven,Lowe Val,Manly Jennifer,Mosley Thomas,Petersen Ronald,Rissman Robert,Schirmer Markus,Schwab Kristin,Seshadri Sudha,Sherman Alexander,Vemuri Prashanthi,Viswanathan Anand,

Affiliation:

1. J. Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston (N.S.R., S.M.G.).

2. Department of Neurology, Mayo Clinic, Jacksonville, FL (J.F.M.).

3. Department of Neurology, Johns Hopkins University, Baltimore, MD (R.G.).

4. Duke University, Durham, NC (L.W.).

5. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston (K.H.).

Abstract

Stroke is a leading cause of the adult disability epidemic in the United States, with a major contribution from poststroke cognitive impairment and dementia (PSCID), the rates of which are disproportionally high among the health disparity populations. Despite the PSCID’s overwhelming impact on public health, a knowledge gap exists with regard to the complex interaction between the acute stroke event and highly prevalent preexisting brain pathology related to cerebrovascular and Alzheimer disease or related dementia. Understanding the factors that modulate PSCID risk in relation to index stroke event is critically important for developing personalized prognostication of PSCID, targeted interventions to prevent it, and for informing future clinical trial design. The DISCOVERY study (Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery), a collaborative network of thirty clinical performance clinical sites with access to acute stroke populations and the expertise and capacity for systematic assessment of PSCID will address this critical challenge. DISCOVERY is a prospective, multicenter, observational, nested-cohort study of 8000 nondemented ischemic and hemorrhagic stroke patients enrolled at the time of index stroke and followed for a minimum of 2 years, with serial cognitive evaluations and assessments of functional outcome, with subsets undergoing research magnetic resonance imaging and positron emission tomography and comprehensive genetic/genomic and fluid biomarker testing. The overall scientific objective of this study is to elucidate mechanisms of brain resilience and susceptibility to PSCID in diverse US populations based on complex interplay between life-course exposure to multiple vascular risk factors, preexisting burden of microvascular and neurodegenerative pathology, the effect of strategic acute stroke lesions, and the mediating effect of genomic and epigenomic variation.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3